Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 250 participants.

Also called NCT05007925

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 250 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05007925
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05007925. Allocation not applicable; no masking; primary purpose treatment. Start 2021-11-18 (actual); primary completion 2024-03-25 (actual). Results posted on 2025-08-05.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System
Condition
Peripheral Artery Disease
Intervention (Device)
Intravascular Lithotripsy
Lead sponsor
Shockwave Medical, Inc. (class: industry)

Record details

Record id
cardio:ct-nct05007925
Content hash
6d2eabaa591c0c16ece892666c964a8625a4903229ef55def282dbe190c5e01e